Clinical Trial Update: Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating a vaccine therapy in patients with stage II–IV malignant melanoma of the skin; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma of the Skin

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Melanoma (Skin) | Phase 1, Phase 2 | Status: UNKNOWN